| scholarly article | Q13442814 |
| P50 | author | Adam J Ratner | Q37378135 |
| P2093 | author name string | A Prince | |
| E DiMango | |||
| R Bryan | |||
| S Tabibi | |||
| P2860 | cites work | Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8 | Q41277486 |
| Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis | Q41283113 | ||
| Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids | Q41283123 | ||
| CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells | Q41507396 | ||
| An Immortalized Cystic Fibrosis Tracheal Epithelial Cell Line Homozygous for the ΔF508 CFTR Mutation | Q41558456 | ||
| Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene | Q41594662 | ||
| A Cystic Fibrosis Bronchial Epithelial Cell Line: Immortalization by Adeno-12-SV40 Infection | Q41689566 | ||
| Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention | Q41829978 | ||
| Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive | Q42816994 | ||
| Role of IL-1 beta and corticosteroids in the regulation of the C/EBP-alpha, beta and delta genes in vivo | Q71145921 | ||
| Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells | Q72037185 | ||
| Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation | Q72105394 | ||
| Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis | Q73091314 | ||
| The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis | Q28303994 | ||
| Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface | Q28368071 | ||
| Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection | Q28493023 | ||
| NF-kappa B subunit-specific regulation of the interleukin-8 promoter | Q28646361 | ||
| Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B | Q29618193 | ||
| NF-kappa B: ten years after | Q29618566 | ||
| Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. | Q33639673 | ||
| Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids | Q33641713 | ||
| Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation | Q33708904 | ||
| Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells | Q33905211 | ||
| Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. | Q34732912 | ||
| Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells | Q34732927 | ||
| Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. | Q34743353 | ||
| Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung | Q35817557 | ||
| Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease | Q35967062 | ||
| Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa | Q37375775 | ||
| Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer | Q37376029 | ||
| Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase | Q37477854 | ||
| C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes | Q38292175 | ||
| Epithelial cells as sensors for microbial infection | Q39786521 | ||
| Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells | Q39795545 | ||
| Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa | Q40155245 | ||
| Nuclear factor kappa B, a mediator of lipopolysaccharide effects | Q40825105 | ||
| Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor kappaB and activator protein 1 and the induction of inflammatory cytokines | Q41098913 | ||
| Phosphorylation-dependent block of cystic fibrosis transmembrane conductance regulator chloride channel by exogenous R domain protein | Q41213204 | ||
| Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli | Q41223294 | ||
| Inflammatory cytokines in cystic fibrosis lungs | Q41266633 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| cystic fibrosis | Q178194 | ||
| NF-κB | Q411114 | ||
| P304 | page(s) | 2598-2605 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells | |
| P478 | volume | 101 |
| Q51470852 | (n-3) long-chain PUFA differentially affect resistance to Pseudomonas aeruginosa infection of male and female cftr-/- mice. |
| Q37114758 | Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells |
| Q47733248 | Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus |
| Q46125947 | Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model |
| Q38314979 | Anti-inflammatory gene therapy directed at the airway epithelium |
| Q39746031 | Apoptotic Response of Chang Cells to Infection with Pseudomonas aeruginosa Strains PAK and PAO-I: Molecular Ordering of the Apoptosis Signaling Cascade and Role of Type IV Pili |
| Q40185293 | Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells |
| Q24309171 | Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling |
| Q40014786 | Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells |
| Q40711765 | Bradykinin increases IL-8 generation in airway epithelial cells via COX-2-derived prostanoids |
| Q38726388 | CFTR Controls the Activity of NF-κB by Enhancing the Degradation of TRADD. |
| Q33413105 | CFTR is a negative regulator of NFkappaB mediated innate immune response |
| Q34067800 | CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation |
| Q39474714 | CFTR negatively regulates cyclooxygenase-2-PGE(2) positive feedback loop in inflammation |
| Q40103054 | CFTR reduces microtubule-dependent Campylobacter jejuni invasion |
| Q39314424 | CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer |
| Q33598904 | CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia |
| Q33868825 | Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor |
| Q38085109 | Cellular and molecular biology of airway mucins |
| Q43964483 | Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid |
| Q36981240 | Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling |
| Q28534023 | Comparative molecular docking analysis of cytoplasmic dynein light chain DYNLL1 with pilin to explore the molecular mechanism of pathogenesis caused by Pseudomonas aeruginosa PAO |
| Q24796048 | Construction of predictive promoter models on the example of antibacterial response of human epithelial cells |
| Q39877846 | Corr4A and VRT325 do not reduce the inflammatory response to P. aeruginosa in human cystic fibrosis airway epithelial cells |
| Q36579774 | Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress. |
| Q35810067 | Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers |
| Q33771634 | Cystic fibrosis-related bone disease: insights into a growing problem |
| Q33807353 | Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases |
| Q73873093 | Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes |
| Q40545728 | Cytokine stimulation by Pseudomonas aeruginosa--strain variation and modulation by pulmonary surfactant |
| Q33249392 | De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cells |
| Q40680220 | Defective activation of c-Src in cystic fibrosis airway epithelial cells results in loss of tumor necrosis factor-alpha-induced gap junction regulation |
| Q40740154 | DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs |
| Q24562089 | Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells |
| Q33717303 | Disruption of interleukin-1β autocrine signaling rescues complex I activity and improves ROS levels in immortalized epithelial cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function |
| Q28575323 | Down-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia |
| Q40314061 | Downregulation by a long-acting beta2-adrenergic receptor agonist and corticosteroid of Staphylococcus aureus-induced airway epithelial inflammatory mediator production |
| Q37406380 | Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences. |
| Q46525235 | Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis. |
| Q40521090 | Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line |
| Q40083107 | Effects of cystic fibrosis transmembrane conductance regulator and DeltaF508CFTR on inflammatory response, ER stress, and Ca2+ of airway epithelia. |
| Q35609604 | Enhanced Ca2+ entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fibrosis airways |
| Q42492799 | Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells |
| Q39678214 | Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling |
| Q35573072 | Fas and Fas ligand expression in cystic fibrosis airway epithelium |
| Q36956172 | Flagellin-stimulated Cl- secretion and innate immune responses in airway epithelia: role for p38. |
| Q38994609 | Host cell polarity proteins participate in innate immunity to Pseudomonas aeruginosa infection |
| Q28216541 | Hyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cells |
| Q37206228 | Hyperinflammation in airways of cystic fibrosis patients: what's new? |
| Q30438358 | IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. |
| Q36779660 | Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis |
| Q24672751 | Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia |
| Q39825776 | Impaired interleukin-8 chemokine secretion by staphylococcus aureus-activated epithelium and T-cell chemotaxis in cystic fibrosis. |
| Q34355411 | Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein |
| Q34007570 | Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae |
| Q38579962 | Inflammation and its genesis in cystic fibrosis |
| Q42527351 | Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. |
| Q42485804 | Innate immune responses of human tracheal epithelium to Pseudomonas aeruginosa flagellin, TNF-alpha, and IL-1beta. |
| Q42483927 | Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation |
| Q51723912 | Interaction of cblA/adhesin-positive Burkholderia cepacia with squamous epithelium. |
| Q35211777 | Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs |
| Q37494912 | Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered |
| Q38046769 | Ion channels/transporters as epigenetic regulators? -a microRNA perspective |
| Q33489607 | Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice |
| Q39518168 | Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells |
| Q33933051 | Lactoperoxidase. New recognition of an "old" enzyme in airway defenses |
| Q36895297 | Life at the front: dissecting bacterial-host interactions at the ocular surface. |
| Q30080000 | Lung infections associated with cystic fibrosis |
| Q40014245 | Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. |
| Q39663303 | Modulation of cytosolic Ca(2+) concentration in airway epithelial cells by Pseudomonas aeruginosa |
| Q35749944 | Molecular basis for the chloride channel activity of cystic fibrosis transmembrane conductance regulator and the consequences of disease-causing mutations |
| Q34773489 | Monitoring inflammation in CF. Cytokines |
| Q73768958 | NF-kappa B may determine whether epithelial cell--microbial interactions in the intestine are hostile or friendly |
| Q31676670 | NF-kappa B mediates up-regulation of CFTR gene expression in Calu-3 cells by interleukin-1beta |
| Q47903430 | NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa |
| Q64378512 | New therapeutic approaches for cystic fibrosis lung disease |
| Q34974166 | Normal CFTR inhibits epidermal growth factor receptor-dependent pro-inflammatory chemokine production in human airway epithelial cells |
| Q44551602 | Okadaic acid induces sustained activation of NFkappaB and degradation of the nuclear IkappaBalpha in human neutrophils |
| Q50848634 | Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis. |
| Q28484221 | PEI-engineered respirable particles delivering a decoy oligonucleotide to NF-κB: inhibiting MUC2 expression in LPS-stimulated airway epithelial cells |
| Q39456654 | Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cells |
| Q36032639 | Pathogen-host interactions in Pseudomonas aeruginosa pneumonia |
| Q35557791 | Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis |
| Q36846425 | Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium |
| Q35012421 | Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis |
| Q40116337 | Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis |
| Q34811102 | Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif |
| Q35557381 | Potential of anti-inflammatory treatment for cystic fibrosis lung disease |
| Q40629637 | Pro-inflammatory effects ofBurkholderia cepaciaon cystic fibrosis respiratory epithelium |
| Q28208128 | Production of beta-defensin-2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein |
| Q40830995 | Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines |
| Q51720480 | Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. |
| Q37310758 | Protective Effect of Caffeic Acid Phenethyl Ester (CAPE) on Amiodarone-Induced Pulmonary Fibrosisin Rat |
| Q40618435 | Pseudomonas aeruginosa Flagella Activate Airway Epithelial Cells through asialoGM1 and Toll-Like Receptor 2 as well as Toll-Like Receptor 5 |
| Q33522442 | Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. |
| Q28472320 | Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection |
| Q40857274 | Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors |
| Q44953860 | Pseudomonas aeruginosa stimulates phosphorylation of the airway epithelial membrane glycoprotein Muc1 and activates MAP kinase |
| Q53691450 | Pulmonary Regnase-1 orchestrates the interplay of epithelium and adaptive immune systems to protect against pneumonia. |
| Q35842184 | Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells. |
| Q24813793 | Relation of exaggerated cytokine responses of CF airway epithelial cells to PAO1 adherence |
| Q64258896 | Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of |
| Q38309835 | Role of Ca2+ in responses of airway epithelia to Pseudomonas aeruginosa, flagellin, ATP, and thapsigargin |
| Q44972950 | Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice |
| Q42919046 | Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation |
| Q37319950 | Role of macrolide therapy in chronic obstructive pulmonary disease |
| Q36378783 | Roles of apoptosis in airway epithelia |
| Q34077907 | SERCA2 regulates non-CF and CF airway epithelial cell response to ozone |
| Q37303197 | Salmonella typhimurium induces epithelial IL-8 expression via Ca(2+)-mediated activation of the NF-kappaB pathway |
| Q40696190 | Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells |
| Q36891552 | Sputum biomarkers of inflammation in cystic fibrosis lung disease |
| Q34116496 | Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung |
| Q38305374 | Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling |
| Q54465071 | Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. |
| Q24802489 | State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? |
| Q38072996 | Structure and function of the Type III secretion system of Pseudomonas aeruginosa |
| Q38337325 | Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-κB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells |
| Q33927605 | Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces |
| Q33765010 | TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. |
| Q40555493 | TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells |
| Q40000299 | TLR2 regulates gap junction intercellular communication in airway cells |
| Q54701109 | The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. |
| Q37273830 | The effect of cyclosporin A on airway cell proinflammatory signaling and pneumonia |
| Q48137311 | The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells. |
| Q78204686 | The protease-antiprotease battle in the cystic fibrosis lung |
| Q34773499 | The role of inflammation in the pathophysiology of CF lung disease |
| Q35627680 | The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy |
| Q30306585 | The role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis |
| Q37421287 | The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease |
| Q30955683 | The two-component sensor response regulator RoxS/RoxR plays a role in Pseudomonas aeruginosa interactions with airway epithelial cells |
| Q36447018 | Toll-like receptor 2 represses nonpilus adhesin-induced signaling in acute infections with the Pseudomonas aeruginosa pilA mutant. |
| Q38293726 | Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells |
| Q36139057 | Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease |
| Q38359766 | Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency |
| Q33298018 | Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis. |
| Q33806101 | Yet another role for the cystic fibrosis transmembrane conductance regulator |
| Q73595361 | [Primary nasal epithelial cells and fibroblasts have inflammation-inducing functions] |
| Q84341396 | [Pulmonary inflammation in cystic fibrosis] |
| Q36977348 | cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells |
| Q91707946 | miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis |
Search more.